EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSMAMG00000009517
Gene Symbol: AURKA
2 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMAMG00000026263
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSMAMG00000024557
Gene Symbol: LOC113131083
2 Cross references
216 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSMAMG00000028249
Gene Symbol: LOC113142966
2 Cross references
192 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMAMG00000013436
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSMAMG00000006122
Gene Symbol: BDKRB1
3 Cross references
147 Possible Orthologues:

C-Abl Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSMAMG00000012709
Gene Symbol: ABL1
2 Cross references
202 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSMAMG00000000396
Gene Symbol: LOC113134803
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSMAMG00000006588
Gene Symbol: LOC113127830
2 Cross references
193 Possible Orthologues:

Cgmp-Inhibited 3',5'-Cyclic Phosphodiesterase A-Like

Ensembl ID : ENSMAMG00000007910
Gene Symbol: LOC113136884
2 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSMAMG00000010532
Gene Symbol: CACNA1C
3 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSMAMG00000023801
Gene Symbol: CACNA1DA
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).